SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-069338
Filing Date
2024-08-15
Accepted
2024-08-15 07:00:31
Documents
15
Period of Report
2024-08-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0211475-8k_abvc.htm   iXBRL 8-K 25889
2 PRESS RELEASE ea021147501ex99-1_abvc.htm EX-99.1 30542
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2336
  Complete submission text file 0001213900-24-069338.txt   241850

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE abvc-20240815.xsd EX-101.SCH 3039
5 XBRL LABEL FILE abvc-20240815_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE abvc-20240815_pre.xml EX-101.PRE 22375
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0211475-8k_abvc_htm.xml XML 3568
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 241210585
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)